Performance of ultra-sensitive electrochemiluminescence LAM assay for diagnosing tuberculosis in HIV-negative individuals: a multicentre, prospective diagnostic study - Top-Institutions - MDSpire

Performance of ultra-sensitive electrochemiluminescence LAM assay for diagnosing tuberculosis in HIV-negative individuals: a multicentre, prospective diagnostic study

  • By

  • Yuanyuan Shang

  • Jiachang Zhang

  • Wenli Cao

  • Mingui Lin

  • Yilin Wang

  • Lili Wang

  • Leping Zhong

  • Xiaohui Wang

  • Wenjing Hou

  • Wei Xu

  • Guiping Wu

  • Junfeng Wu

  • Yu Pang

  • Xinting Yang

  • June 22, 2026

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Beijing Tsinghua Changgung Hospital
    Beijing Tsinghua Changgung Hospital

    Beijing, China

    Key Differentiators

    • Infectious Disease

  • #2

    Beijing Chest Hospital
    Beijing Chest Hospital

    Beijing, China

    Key Differentiators

    • Infectious Disease

  • #3

    Capital Medical University
    Capital Medical University

    Beijing, China

    Key Differentiators

    • Infectious Disease

  • #4

    Beijing Geriatric Hospital
    Beijing Geriatric Hospital

    Beijing, China

    Key Differentiators

    • Infectious Disease

  • #5

    Centre de Recherches Médicales de Lambaréné
    Centre de Recherches Médicales de Lambaréné

    Lambaréné, Gabon

    Key Differentiators

    • Infectious Disease

Original Source(s)

Performance of ultra-sensitive electrochemiluminescence LAM assay for diagnosing tuberculosis in HIV-negative individuals: a multicentre, prospective diagnostic study

  • by Yuanyuan Shang, Jiachang Zhang, Wenli Cao, Mingui Lin, Yilin Wang, Lili Wang, Leping Zhong, Xiaohui Wang, Wenjing Hou, Wei Xu, Guiping Wu, Junfeng Wu, Yu Pang, Xinting Yang

  • June 22, 2026

Related Content

Why the Test-Negative Design Is Used for Routine Vaccine Monitoring

HBV pgRNA induces chronic inflammation in an IL-1β-dependent manner

Case Report: Early documented infected pancreatic necrosis due to carbapenem-resistant Acinetobacter baumannii and concurrent Enterococcus faecium bacteremia: a salvage regimen with sulbactam-durlobactam and tigecycline